The customer received questionable ionized calcium (ca2+) results for one patient.The patient was under "hemo-filtration treatment in icu" therefore the patient's blood contained citric acid as an anti-coagulant which may have affected the results.The results from the cobas b123 were <0.1 mmol/l and 1.069 mmol/l.On (b)(6) 2018, the result was <0.1 mmol/l with a data flag.The results from a cobas b221 analyzer were 0.250 mmol/l with a data flag and 1.263 mmol/l.On (b)(6) 2018, the result was 0.217 mmol/l with a data flag, no erroneous result was reported outside of the laboratory.There was no allegation of an adverse event.The reagent lot number and expiration date were requested but were not provided.As part of troubleshooting, the customer performed comparison testing between the cobas b123 and cobas b221 using heparin, citric acid, and blood gas needles as the anti-coagulant.The qc results for each analyzer were acceptable.
|
The investigation found the customer's use of citric acid as an anti-coagulant was the cause of the issue.Product labeling states heparin salts are the only permitted anticoagulants for analyses in the cobas b 123 poc system.Other anticoagulants, such as edta, citrate, oxalates, fluorides and ammonia-containing anticoagulants have a significant effect on the blood ph value and other parameters and thus must not be used.
|